The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Wednesday, November 15, 2023
Legend Biotech Corporation announced that Legend Biotech Ireland Limited, a wholly owned subsidiary of Legend Biotech, has entered into an exclusive, ...
read more
Thursday, November 09, 2023
908 Devices Inc. a provider of purpose-built handheld and desktop devices for chemical and biochemical analysis, and medical technology company Terumo...
read more
Thursday, November 02, 2023
AstraZeneca announced a collaboration and investment agreement with Cellectis, a clinical-stage biotechnology company, to accelerate the development ...
read more
Daiichi Sankyo and Merck have entered into a global development and commercialization agreement for three of Daiichi Sankyo’s DXd antibody drug ...
read more
Tuesday, October 17, 2023
The Life Science Group Sartorius introduces the Picus® 2 Electronic Pipette, the latest addition to its portfolio of electronic pipettes. With a ...
read more
Wednesday, October 11, 2023
Multiply Labs, a robotics company developing automated manufacturing systems to produce individualized drugs (including but not limited to cell ...
read more
Thermo Fisher Scientific announced it has expanded its manufacturing capacity in St. Louis to support biologic therapies for diseases ranging from ...
read more
Thursday, October 05, 2023
Lonza announced an extension of a long-term collaboration with a major global biopharmaceutical partner.
read more
Wednesday, September 27, 2023
Theradaptive, a biopharmaceutical company using protein engineering to create targeted therapeutics, has been awarded a U.S. Department of Defense (...
read more
Thursday, September 21, 2023
The FDA granted Orphan Drug Designation (ODD) designation for NXC-201 for the treatment of a life-threatening blood disorder, Amyloid Light Chain (AL)...
read more
Wednesday, September 20, 2023
Alexion, AstraZeneca Rare Disease, has completed a definitive purchase and license agreement for a portfolio of preclinical rare disease gene therapy ...
read more
Tuesday, September 19, 2023
Nexcella, Inc., a clinical-stage biopharmaceutical company engaged in the discovery and development of novel cell therapies for oncology and other ...
read more
Tuesday, September 19, 2023
ALSA Ventures, a UK-based, therapeutics-focused venture capital fund, announced the acquisition of Axovia Therapeutics Inc and the launch of a new ...
read more
Thursday, September 07, 2023
Eminence Biotechnology’s state-of-the-art facility for the commercial production of cell culture media is now fully operational.
read more
Tuesday, September 05, 2023
SomaLogic, Inc., a provider of proteomics technology, announced that it is extending its collaborative agreement with Novo Nordisk.
read more